European National Pathology Congresses

Revolutionising precision oncology: new biomarker identification with 1-day NGS

Biomarker testing in precision oncology: a European revolution

Even in these hard times, our thought leaders virtually presented their experiences with our Oncomine™ NGS solutions in the most important European national pathology congresses. Have you missed the opportunity to join us in one of our satellite symposia during 2021?

Now you have the possibility to access all our on-demand content in local language and discover how NGS can be as fast and easy as IHC allowing your lab to test latest and established relevant biomarkers in a single day.

Choose the topic you are interested the most to learn more on:

The Promise of 1-Day Easy NGS

Discover how to deliver NGS results at the same time as other single-gene methods with the Ion Torrent™ Genexus™ System.

 

spain RNA-based next generation sequencing para la detección de fusiones

Prof. Fernando Lopez-Rios, Universidad CEU San Pablo, Spain

Download Slides

 

 

spain Análisis de Secuenciación Masiva automatizada mediante Genexus en tumores sólidos

Prof. Xavier Hernandez Losa, Vall d'Hebron University Hospital, Spain

Download Slides

 

germany Zukünftige therapierelevante Veränderungen per NGS in nur einem Tag

Prof. Michael Hummel, Charité CCC, Germany

Download Slides

 

uk The use of Genexus system and Oncomine™ Precision Assay as fast and sensitive NGS solution for solid tumour molecular characterisation

Dr. Hana Lango Allen, East Genomic Laboratory Hub, UK

Download Slides

 

uk Verification of next generation sequencing in the pathology department Cork University Hospital

Dr. Reiltin Werner, Cork University Hospital, Ireland

Download Slides

 

italy Utilizzo del Genexus per la profilazione molecorare dei tumori in NGS

Dr. Annarita Destro, Humanitas Research Hospital, Italy

Download Slides

 

uk The economic advantage of 1-day NGS

Dr. Javier Hernandez Losa, Director of Molecular Biology Laboratory, Pathology Department, Vall d'Hebron University Hospital, Spain

Download Slides

 

uk Pivoting from Cancer to COVID-19 in a global pandemic​

Dr. Paul Hofman, MD, PhD, Laboratory of Clinical and Experimental Pathology, Louis Pasteur Hospital, Nice, France

Download Slides

Oncologist Perspective on Molecular Testing

Listen to European oncologists and learn from them how NGS based molecular characterisation of tumour samples will provide a rational and highly promising approach for guiding oncologists in treatment decision-making.

 

spain-1 Visión del Oncólogo de la Medicina de Precisión

Prof. Mariano Provencio, Hospital Universitario Puerta de Hierro, Spain

Download Slides

 

uk Precision Medicine: Oncologist perspective on the impact of the molecular evaluation of solid tumour

Prof. Mariano Provencio, Hospital Universitario Puerta de Hierro, Spain

Download Slides

 

italy Il paradigma in evoluzione della medicina di precisione nel cancro del polmone La prospettiva dell'oncologo

Dr. Francesco Passiglia, University of Turin, Italy

Download Slides

 

italy Ricadute pratiche della caratterizzazione molecolare multigenica in oncologia

Dr. Carlo Genova, Ospedale Policlinico San Martino, Italy

Download Slides

 

germany Selpercatinib – der erste zugelassene spezifische RET-Inhibitor im Einsatz

Dr. Damian Rieke, Charité – Universitätsmedizin Berlin, Germany

Download Slides

One Size Does Not Fit All

Gain more detailed insights faster with the complete Oncomine solid tumour NGS workflow solution. Listen to our users and discover our broad assay menu from targeted to comprehensive genomic profiling, with the smallest sample input requirements in the industry. Learn from them how to analyse more samples and produce complete bioinformatic reports that drive key insights.

 

spain-1 Estudio molecular del cáncer de pulmón: De los métodos convencionales a la NGS

Dr. Yolanda Ruano Dominguez, Hospital 12 de Octubre, Spain

Download Slides

uk Clinical research on genomic profiling using the Oncomine™ Comprehensive Assay Plus

Dr. Ines Raineri, Institute for Pathology Medica AG, Switzerland

Download Slides

 

germany Homologous Recombination Repair Deficiency HRD

Dr. Andreas Jung, University of Munich, Germany

Download Slides

 

germany RET als Tumormarker beim NSCLC und Schilddrüsenkarzinom

Prof. Dr. Peter Wild, Universitätsklinikum Frankfurt, Germany

Download Slides

 

italy Multicentric study to evaluate
in-house solution for CGP

Dr. Massimo Barberis, Istituto Europeo di Oncologia, Italy

Download Slides

 

uk The role of comprehensive genomic profiling in emerging biomarker testing

Dr. Nicola Normanno, Director of Department of Experimental Oncology, INT-Fondazione Pascale, Naples, Italy

Download Slides

 

uk Algorithms to use different sizes of panels for different types of cancer samples - experience in a molecular pathology lab

Prof. Dr. Peter Wild, Director of Dr. Senckenberg Institute for Pathology, University Hospital Frankfurt, Germany

Download Slides

 

uk Introduction to multi-biomarker profiling: what is the data saying about it?

Dr. Jose Luis Costa, EMEA Medical Affairs Director,
Thermo Fisher Scientific

Download Slides

 

uk Multicentric study to evaluate in-house solution for CGP

Dr. Massimo Barberis, Director of Histopathology and Molecular Diagnostics Unit, European Institute of Oncology, Italy

Download Slides

 

uk Comprehensive genomic profiling with the Oncomine Comprehensive Assay Plus

Ilaria Alborelli, PhD, Clinical Data Analyst, Institute of Pathology and Medical Genetics, University Hospital Basel, Switzerland

Download Slides

Would you like to speak with a Thermo Fisher Scientific representative?
Click the button below to request contact.

request-contact-cta

Would you like to speak with a Thermo Fisher Scientific representative?
Click the button below to request contact.

request-contact-cta

 

For Research Use only. Not for use in diagnostic procedures.